CFTR and cystic fibrosis: Indeed, this alkaline treatment could be administered to patients carried of p.F508del-CFTR mutation together with modulators of CFTR activity and to CF patients with other not pharmacologically treatable CFTR mutations on order to ameliorate the respiratory phenotype associated to the CF disease [21].